[1]李帅,周志刚#,高剑波,等.CT引导下组织间植入125I粒子联合替吉奥治疗老年胰腺癌疗效分析[J].郑州大学学报(医学版),2015,(02):270.
 LI Shuai,ZHOU Zhigang,GAO Jianbo,et al.Efficacy of CTguided implantation of 125I seeds combined with S1 in treatment of pancreatic cancer in elderly patients[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2015,(02):270.
点击复制

CT引导下组织间植入125I粒子联合替吉奥治疗老年胰腺癌疗效分析
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2015年02期
页码:
270
栏目:
应用研究
出版日期:
2015-03-20

文章信息/Info

Title:
Efficacy of CTguided implantation of 125I seeds combined with S1 in treatment of pancreatic cancer in elderly patients
作者:
李帅周志刚#高剑波潘元威王猛
郑州大学第一附属医院放射科 郑州 450052
Author(s):
LI Shuai ZHOU Zhigang GAO Jianbo PAN Yuanwei WANG Meng
Department of Radiology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052
关键词:
老年胰腺癌125I粒子替吉奥
Keywords:
elderly pancreatic cancer125I seedS1
分类号:
R735.9
摘要:
目的:评价125I粒子组织间植入联合替吉奥胶囊化疗在治疗老年胰腺癌中的临床价值。方法:51例老年胰腺癌患者分为2组:观察组27例行125I粒子植入联合替吉奥胶囊化疗,对照组24例行替吉奥单药化疗;对比2组疗效、毒性反应及临床受益反应,并应用KaplanMeier 法绘制生存曲线。结果:观察组有效率为70.4%,对照组为37.5%(χ2=5.545,P=0.019);观察组疾病控制率为92.6%,对照组为62.5%(χ2=0.966,P=0.326)。观察组临床受益反应有效率为55.6%,对照组为25.0%(Z=2.476,P=0.013)。2组毒性反应发生率比较,差异无统计学意义(χ2=0.919,P=0.406)。观察组中位生存期为11.0(9.7~12.2)个月,6、12个月生存率分别为87.8%、27.7%;对照组分别为8.0(6.6~9.3)个月和67.8%、10.4%(Z=8.029,P=0.005)。结论:125I粒子组织间植入联合替吉奥化疗治疗老年胰腺癌临床疗效明确,可有效延长生存期。
Abstract:
Aim: To evaluate the clinical effect of 125I seeds implantation combined with chemotherapy of S1 in the treatment of pancreatic cancer in elderly patients.Methods: Clinical data of 51 pancreatic cancer patients were analyzed. The observation group(27 patients) were treated by CTguided 125I seed implantation combined with chemotherapy of S1.The control group(24 patients) were treated by chemotherapy of S1. The curative effect, toxic response and clinical benefit response were compared, survival curve was drown by KaplanMeier method. Results: The effective rate of the observation group was 70.4%, and that of the control group was 37.5%(χ2=5.545,P=0.019). The disease control rate of the observation group was 92.6%, and that of the control group was 62.5%(χ2=0.966,P=0.326).The clinical benefit response rate of the observation group was 55.6%, and that of the control group was 25.0%(Z=2.476,P=0.013).The toxic reaction between observation group and control group had no significant difference(χ2=0.919,P=0.406). The median survival time of the observation group was 11.0(9.7~12.2) months, the survival rates of 6 and 12 months were 87.8% and 27.7%, and those of the control group were 8.0(6.6~9.3) months, 67.8% and 10.4%(Z=8.029,P=0.005).Conclusion: 125I seeds implantation combined with chemotherapy of S1 in treatment of pancreatic cancer in elderly patients has an affirmative clinical efficacy and could effectively prolong survival.

参考文献/References:

[1]Jemal A,Siegel R,Ward E,et al.Cancer statistics, 2008[J].CA Cancer J Clin,2008,58(2):71 [2]Laheru D,Biedrzycki B,Thomas AM,et al.Development of a cytokinemodified sllogeneic whole cell pancreatic cancer vaccine[J].Methods Mol Med,2005,103:299 [3]Heinemann V.Gemcitabinebased combination treatment of pancreatic cancer[J].Semin Oncol,2002,29(1 Suppl 3):25 [4]Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15(6):2403 [5]陈万青,王庆生,张思维,等.2003~2007年中国胰腺癌发病与死亡分析[J].中国肿瘤,2012,21(4):248 [6]Zhang FJ,Li CX,Jiao DC,et al.CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma[J].Chin Med J (Engl),2008,121(23):2410 [7]Ueno H,Ioka T,Ikeda M,et al.Randomized phase Ⅲ study of gemcitabine plus S1, S1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study[J].J Clin Oncol,2013,31(13):1640 [8]孙勇,高剑波,周志刚,等.CT引导下125I粒子植入联合化疗治疗晚期胰腺癌25例体会[J].郑州大学学报:医学版,2009,44(6):1273 [9]郭旭,李闻,蔡逢春,等.放射性125I粒子治疗老年胰腺癌的临床研究[J].实用临床医药杂志,2013,17(5):133[10]董良鹏,秦双,李岩,等.替吉奥联合同步放疗治疗局部晚期胰腺癌20例[J].中国老年学杂志,2013,33(18):4529 [11]司佩任,路筝,刘岩,等.125I籽源短时低剂量率照射对胰腺癌神经生长因子表达的影响[J].中华胰腺病杂志,2014,14(2):126 (20141008收稿责任编辑姜春霞)

更新日期/Last Update: 1900-01-01